methyl 2-(2-imino-6-(methylthio)benzo[d]thiazol-3(2H)-yl)acetate hydrobromide, 95.0%, 250mg

Pyrazolo[1,5-a]pyrimidine-5,7-diamine, N5-(6-aminohexyl)-3-(1-methylethyl)-N7-(phenylmethyl)-, hydrochloride (1:1), 100mg

2,2-Dimethyl-4-oxo-3,8,11-trioxa-5-azatridecan-13-oic acid, 97.0%, 1g

4-(1H-Pyrazol-1-yl)piperidine, 95.0%, 5g

6,6'-dihydroxy-5,5'-dimethoxybiphenyl-3,3'-dicarbaldehyde, 97%, 250mg

Ethyl 2-(trifluoromethyl)pyrimidine-5-carboxylate, 95.0%, 250mg

Fmoc-D-Arg-OH, 95.0%, 5g

tert-Butyl 6-bromo-1-oxo-1,3-dihydrospiro[indene-2,4'-piperidine]-1'-carboxylate, 97%, 1g

N,N-Diethyl-m-toluidine [for Biochemical Research]>99.0%(GC)1g

3,6,9,12,15,18,21-Heptaoxatricosanedioic acid, 97%, 250mg

tert-Butyl 4-[2-(aminomethyl)phenyl]piperazine-1-carboxylate, 95+%, 250mg

Aprocitentan, 10mg

Water, ISO 3696 Type 3, demineralized, 1L, plastic packaging.